Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: A review

Authors
Citation
B. Settergren, Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: A review, SC J IN DIS, 32(2), 2000, pp. 125-132
Citations number
81
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00365548 → ACNP
Volume
32
Issue
2
Year of publication
2000
Pages
125 - 132
Database
ISI
SICI code
0036-5548(2000)32:2<125:CAONE(>2.0.ZU;2-G
Abstract
Nephropathia epidemica (NE) is a prevalent zoonosis throughout Europe and i s caused by the Puumala type of hantavirus, The incidence of NE varies in a cyclic fashion, with peaks occurring every 3rd to 4th year, coinciding wit h peaks in vole populations. The clinical course of NE is generally milder than haemorrhagic fever with renal syndrome caused by hantaviruses in other parts of the world, Typically, NE has a sudden onset with fever, headache, backpain and gastrointestinal symptoms. However, severe complications, e.g , gastrointestinal haemorrhage, occur and fatal cases have been reported. R enal involvement is prominent and manifests as initial oliguria and later a s marked polyuria. Tests of renal function show pronounced glomerular and t ubular involvement. Vaccine against Puumala virus infection as well as spec ific treatment for NE are still lacking.